tariquidar has been researched along with flumazenil in 1 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (flumazenil) | Trials (flumazenil) | Recent Studies (post-2010) (flumazenil) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 4,673 | 426 | 981 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Lange, EC; Eriksson, J; Labots, M; Lammertsma, AA; Syvänen, S; Tagawa, Y; Voskuyl, RA; Windhorst, AD | 1 |
1 other study(ies) available for tariquidar and flumazenil
| Article | Year |
|---|---|
Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Carbon Radioisotopes; Epilepsy; Flumazenil; Kainic Acid; Male; Positron-Emission Tomography; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2012 |